FY2028 Earnings Forecast for Insmed Issued By HC Wainwright
Insmed Incorporated (NASDAQ:INSM – Free Report) – Investment analysts at HC Wainwright lifted their FY2028 earnings per share estimates for shares of Insmed in a research report issued on Wednesday, June 11th. HC Wainwright analyst A. Fein now forecasts that the biopharmaceutical company will post earnings per share of $2.63 for the year, up from […]
